staurosporine has been researched along with trimetrexate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arkin, H; Holland, JF; Ohnuma, T; Schwartz, GK | 1 |
| Bhushan, A; Birge, RB; Calman, NS; Hacker, MP; Kimberly, PJ; Kupperman, JL; Newell, MK; Stone, JE; Tritton, TR | 1 |
2 other study(ies) available for staurosporine and trimetrexate
| Article | Year |
|---|---|
Protein kinase C activity and multidrug resistance in MOLT-3 human lymphoblastic leukemia cells resistant to trimetrexate.
Topics: Alkaloids; Cell Division; Drug Resistance; Humans; In Vitro Techniques; Leukemia, Lymphoid; Protein Kinase C; Quinazolines; Staurosporine; Tetradecanoylphorbol Acetate; Trimetrexate; Tumor Cells, Cultured | 1991 |
Drug resistance results in alterations in expression of immune recognition molecules and failure to express Fas (CD95).
Topics: Animals; Antigens, CD; Antimetabolites, Antineoplastic; Apoptosis; B7-1 Antigen; B7-2 Antigen; Carcinogens; Cell Line; Dose-Response Relationship, Drug; Drug Resistance; fas Receptor; Immune System; Kinetics; Membrane Glycoproteins; Methotrexate; Mice; Staurosporine; Trimetrexate | 1998 |